openPR Logo
Press release

Biologics Market New Product Development & Latest Trends | AbbVie, Amgen, Roche

04-03-2025 09:29 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Exactitude Consultancy

Biologics

Biologics

On April 3, 2025, Exactitude Consultancy., Ltd. released a research report titled "Biologics Market". In-depth research has been compiled to provide the most up-to-date information on key aspects of the worldwide market. This research report covers major aspects of the Biologics Market including drivers, restraints, historical and current trends, regulatory scenarios, and technological advancements. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain, future strategies. Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche Biologics are aligned with your aims.

This report is also available in the following languages : Japanese (生物製剤市場), Korean (생물학 시장), Chinese (生物制剂市场), French (Marché des produits biologiques), German (Markt für Biologika), and Italian (Mercato dei prodotti biologici), etc.

Request for a FREE sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/49003
(Exclusive Offer: We are offering discount of upto 40% on bundled report purchase. Maximum report count 2-4)

The Global Biologics Market Size is projected to reach at a CAGR of 8.5% during 2025-2034. The biologics market is expanding rapidly, fueled by rising chronic diseases, biosimilar development, and personalized therapies. Monoclonal antibodies, vaccines, and gene therapies dominate. Strong pipeline innovations and FDA approvals boost growth. High production costs remain a challenge, but increasing biologics adoption in oncology and immunology sustains market momentum.

Competitive Dashboard:
AbbVie,Amgen,Roche,Johnson & Johnson,Pfizer,Merck & Co.,Bristol Myers Squibb,Sanofi,Novartis,Takeda Pharmaceutical Company,Gilead Sciences,Eli Lilly and Company,AstraZeneca,Biocon,Regeneron Pharmaceuticals

The Biologics Market report is generated through systematic data collection and analysis, including research on individuals, organizations, and social opinions. The global Biologics Market is categorized based on type and application. Players, stakeholders, and other participants in the global market can leverage this research as a valuable resource to gain a competitive edge. The segmental study focuses on production capacity, revenue, and forecasts by type and application for the years 2025-2034.

For More Information or Query, Vist @ https://exactitudeconsultancy.com/check-discount/49003

Global Biologics Market: Segmental Analysis

By Product Type
Monoclonal Antibodies
Vaccines
Cell and Gene Therapy

By Application
Oncology
Infectious Diseases
Autoimmune Disorders

By End User
Hospitals
Research Institutes
Pharmaceutical Companies

By Technology
Recombinant DNA Technology
Monoclonal Antibody Technology

By Distribution Channel
Online Pharmacies
Retail Pharmacies

Countries Covered:

North America (U.S. and Canada)
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
Eastern Europe (Poland and Russia)
Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
Middle East and Africa (GCC, Southern Africa, and North Africa)

Biologics Market Challenges and Risks:
The biologics market is challenged by high development and manufacturing costs, leading to expensive therapies that may limit patient access. Complex regulatory pathways can delay product approvals and market entry. Additionally, the sensitivity of biologic products necessitates stringent storage and handling requirements, posing logistical challenges. Biosimilar competition also introduces pricing pressures and market share concerns for established biologic therapies.

Click Here to Get a Sample Copy of the Latest Research on the Biologics Market in 2025 Before Purchase: https://exactitudeconsultancy.com/request-sample/49003

Table of Content: Biologics Market:
Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Biologics market
Chapter 2: Exclusive Summary - the basic information of the Biologics Market
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Biologics Market
Chapter 4: Presenting the Biologics Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the Biologics market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions (2025-2034)
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

finally, Biologics Market is a valuable source of guidance for individuals and companies.

Discover More: Visit Our Website For Additional Reports!

Asphalt Pumps Market
https://exactitudeconsultancy.com/reports/51469/asphalt-pumps-market

U.S. Chromatography Columns Market
https://exactitudeconsultancy.com/reports/50768/u-s-chromatography-columns-market

Oral Rehydration Solution Market
https://exactitudeconsultancy.com/reports/51019/oral-rehydration-solution-market

Connected Healthcare Market
https://exactitudeconsultancy.com/reports/51169/connected-healthcare-market

Material Lift Rental Market
https://exactitudeconsultancy.com/reports/51319/material-lift-rental-market

Customization Service of the Report:
Exactitude Consultancy provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biologics Market New Product Development & Latest Trends | AbbVie, Amgen, Roche here

News-ID: 3953182 • Views:

More Releases from Exactitude Consultancy

Partial Seizure Market to Reach USD 11.24 Billion by 2034 Driven by Rising Epilepsy Prevalence & Breakthrough Anti-Seizure Therapies
Partial Seizure Market to Reach USD 11.24 Billion by 2034 Driven by Rising Epile …
Pune, India - December 2025 - The global Partial Seizure Market, valued at USD 6.82 billion in 2024, is projected to reach USD 11.24 billion by 2034, growing at a 5.2% CAGR (2025-2034), according to Exactitude Consultancy. Increasing global epilepsy burden, development of new anti-seizure medications (ASMs), and expanded access to neurological diagnostics are fueling strong market growth. Download Full PDF Sample Copy of Market Report https://exactitudeconsultancy.com/request-sample/72069 Market Summary The Partial Seizure Market
Partial Epilepsy Market to Reach USD 9.36 Billion by 2034
Partial Epilepsy Market to Reach USD 9.36 Billion by 2034
Pune, India - December 2025 - The global Partial Epilepsy Market, valued at USD 5.84 billion in 2024, is projected to reach USD 9.36 billion by 2034, growing at a 4.8% CAGR (2025-2034), according to Exactitude Consultancy. Rising prevalence of focal (partial) seizures, development of improved anti-epileptic drugs (AEDs), and advancements in neuroimaging and neuromodulation therapies are key growth drivers. Download Full PDF Sample Copy of Market Report https://exactitudeconsultancy.com/request-sample/72067 Market Summary The Partial
Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market to Reach USD 19.42 Billion by 2034
Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market to Reach USD 1 …
Pune, India - December 2025 - The global Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market, valued at USD 6.84 billion in 2024, is projected to reach USD 19.42 billion by 2034, growing at a robust 11.0% CAGR (2025-2034), according to Exactitude Consultancy. Rapid advancements in AAV-based gene therapies, antisense oligonucleotides (ASOs), RNA-targeting technologies, and improved diagnostic pathways are driving strong market momentum. Download Full PDF Sample Copy of Market
Prediabetes Market to Reach USD 29.84 Billion by 2034 Driven by Rising Global Diabetes Risk & Digital Health Programs
Prediabetes Market to Reach USD 29.84 Billion by 2034 Driven by Rising Global Di …
Pune, India - December 2025 - The global Prediabetes Market, valued at USD 14.62 billion in 2024, is projected to reach USD 29.84 billion by 2034, growing at a 7.2% CAGR (2025-2034), according to Exactitude Consultancy. The rising prevalence of insulin resistance, sedentary lifestyles, obesity, and increased screening initiatives are fueling substantial market growth. Download Full PDF Sample Copy of Market Report https://exactitudeconsultancy.com/request-sample/72063 Market Summary The Prediabetes Market is expanding rapidly as healthcare

All 5 Releases


More Releases for Biologics

Global Biologics Contract Manufacturing Market Set to Reach $83.47 Billion by 20 …
Biologics Contract Manufacturing Market reached US$ 26.03 billion in 2024 and is expected to reach US$ 83.47 billion by 2033, growing at a CAGR of 14.0% during the forecast period 2025-2033. The Biologics Contract Manufacturing market involves outsourcing the production of complex biologic drugs, including vaccines, antibodies, and recombinant proteins. Rising demand for biologics, cost-effective manufacturing, and scalable production drives growth. Technological advancements in cell culture, purification, and quality control enhance
Advanced Biologics Manufacturing Solutions Market Future Business Opportunities …
The qualitative latest Research report (2025-2032) on the Advanced Biologics Manufacturing Solutions Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/137417 Focused on
Biologics Fill Finish Manufacturing Market 2024-2031: Global Industry Size, Shar …
According to a new report published by CoherentMI The Biologics Fill Finish Manufacturing Market is estimated to be valued at USD 5.41 Billion in 2024 and is expected to reach USD 9.04 Billion by 2031, growing at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031. Most recent Report, named "Biologics Fill Finish Manufacturing Market" Patterns, Offer, Size, Development, Opportunity and Forecast 2024-2031, by CoherentMI offers a
Biologics Market
The "Biologics Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031.  The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Biologics Market, 2024-2031 Verified Market Research's most recent report, "Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination of the industry
Biologics Contract Manufacturing Market to Witness Huge Growth by 2031 | Wuxi Bi …
The Biologics Contract Manufacturing Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach. Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/biologics-contract-manufacturing-market What is the
Spine Biologics Market Report 2024 - Spine Biologics Market Trends And Share
"The Business Research Company recently released a comprehensive report on the Global Spine Biologics Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample